DiaMedica Therapeutics Inc. Common Stock (DMAC) is a publicly traded Healthcare sector company. As of May 20, 2026, DMAC trades at $5.34 with a market cap of $306.06M and a P/E ratio of -8.07. DMAC moved -0.79% today. Year to date, DMAC is -29.76%; over the trailing twelve months it is +30.45%. Its 52-week range spans $3.19 to $10.42. Analyst consensus is strong buy with an average price target of $13.00. Rallies surfaces DMAC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DiaMedica Therapeutics Inc. Common Stock (DMAC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DMAC moved -0.79% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $5.34 |
| Market Cap | $306.06M |
| P/E Ratio | -8.07 |
| EPS | $-0.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.42 |
| 52-Week Low | $3.19 |
| Volume | 96 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-32.77M |
| Gross Margin | 0.00% |
3 analysts cover DMAC: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.00.